We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$481M
AUM Growth
-$55.4M
Cap. Flow
-$94.9M
Cap. Flow %
-19.73%
Top 10 Hldgs %
37.24%
Holding
92
New
28
Increased
9
Reduced
23
Closed
26

Top Buys

1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$13.5M
2
NVRO
NEVRO CORP.
NVRO
+$13.2M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$11.6M
4
ENDP
Endo International plc
ENDP
+$8.8M
5
INSM icon
Insmed
INSM
+$8.11M

Top Sells

1
CLVS
Clovis Oncology, Inc.
CLVS
+$12.2M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$9.84M
3
MRK icon
Merck
MRK
+$9.57M
4
ELGX
Endologix Inc
ELGX
+$9.41M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$9.22M

Sector Composition

1 Healthcare 58.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
76
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
– –
-100,000
Closed -$23.6M
VRTX icon
77
Vertex Pharmaceuticals
VRTX
$123B
– –
-90,000
Closed -$9.84M
XENE icon
78
Xenon Pharmaceuticals
XENE
$6.6B
– –
-150,000
Closed -$600K
MRTX
79
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-172,184
Closed -$895K
KDNY
80
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-160,000
Closed -$8.6M
CLVS
81
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-200,000
Closed -$12.2M
AERI
82
CALL
DELISTED
Aerie Pharmaceuticals
AERI
– –
-220,000
Closed -$9.98M
CFMS
83
DELISTED
Conformis, Inc. Common Stock
CFMS
– –
-16,000
Closed -$2.09M
ZSAN
84
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-1,343
Closed -$1.79M
WMGI
85
DELISTED
Wright Medical Group Inc
WMGI
– –
-185,000
Closed -$5.76M
STML
86
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-225,000
Closed -$1.92M
DERM
87
DELISTED
Dermira, Inc.
DERM
– –
-65,000
Closed -$2.22M
AVEO
88
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-150,000
Closed -$885K
ELGX
89
DELISTED
Endologix Inc
ELGX
– –
-130,000
Closed -$9.41M
TSRO
90
CALL
DELISTED
TESARO, Inc.
TSRO
– –
-50,000
Closed -$7.69M
SPNC
91
DELISTED
Spectranetics Corp
SPNC
– –
-155,000
Closed -$4.47M
SHPG
92
DELISTED
Shire pic
SHPG
– –
-30,000
Closed -$5.23M
1 2 3
4

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Ghost Tree Capital held 92 positions worth $481M, down 10% from $537M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ghost Tree Capital withdrew a net $94.9M in Q2 2017, closing 26 positions and reducing 23 holdings. Its most notable exit was Clovis Oncology, Inc., an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 60% a quarter earlier.

Against the trend, Ghost Tree Capital opened a new position in GW Pharmaceuticals Plc American Depositary Shares worth $12.5M.

  • Ghost Tree Capital's largest Q2 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 125,000 shares worth $12.5M.
  • Ghost Tree Capital added most to Seagen Inc. Common Stock in Q2 2017, an estimated $6.36M increase.
  • Ghost Tree Capital's biggest Q2 2017 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $9.22M.
  • Ghost Tree Capital fully exited Clovis Oncology, Inc. in Q2 2017, selling an estimated $12.2M.
  • Ghost Tree Capital's ten largest holdings make up 37% of its $481M portfolio in Q2 2017.
  • Ghost Tree Capital opened 28 new positions and closed 26 in Q2 2017.
  • Ghost Tree Capital's portfolio value fell 10% quarter-over-quarter to $481M.

Based on Ghost Tree Capital's 13F filing for Q2 2017, filed 14 Aug 2017.